GERALDINE MARROCCO: Open Payments
NPI 1083688683 · TRUMBULL, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 16 payments from 5 companies in 2025. Trend: 2023 $406 · 2024 $590 · 2025 $482
Food & beverage: $482
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $232 |
| Lilly USA, LLC | 1 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| Novo Nordisk Inc | 2 | $41 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
Products named: OTEZLA, ZEPBOUND, Kerendia, REPATHA, INGREZZA, Rybelsus.
Industry payments across CT — which companies pay providers there.
